Our website uses cookies to improve your on-site experience. By using the website, cookies are being used as described in our Policy Document
Warning: To log in you will need to enable cookies and reload the page (Policy Document)
My ePortfolio Register   

EADO 2018 /
Do we still need surgery in advanced melanoma?

6th - 9th Nov 2018

Please rate this video

Please complete at least one question.

  1. The information in this video was of interest to me Disagree Agree
  2. The information in this video is likely to improve my clinical practice or research Disagree Agree
  3. I would recommend this video to my colleagues Disagree Agree
Thanks for rating
There has been a problem, please refresh and try again.
Published: 20.11.18
Views: 598

Prof John Thompson - University of Sydney, Sydney, Australia

Prof John Thompson speaks with ecancer at the EADO 2018 congress in Barcelona on whether we still need surgery to treat advanced melanoma.

Prof Thompson believes that, despite recent trials showing no advantage to a completion lymph node dissection, there are still occasions where sentinel node positive patients could require surgery.

He explains that for patients with a metastatic disease such as isolated systemic metastasis similar results or better can be achieved through surgery.

He also outlines that for patients with macroscopic involvement the 10 year survival rate is around 45% with drug therapies not yet having 5 year survival results.

ecancer's filming has been kindly supported by Amgen through the ecancer Global Foundation. ecancer is editorially independent and there is no influence over content.

Previous conferences: highlights

Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

ecancer Global Foundation